Probability of Antibody Formation against Circumsporozoite Protein of Plasmodium vivax among Korean Malaria Patients

• Published in: Korean journal of parasitology 2014, Hosts and Diseases, 52(2), , pp.143-149
• Main Authors: Nam, Ho-Woo, Song, Kyoung Ju, Ahn, Hye Jin, Yang, Zhaoshou, Chong, Chom-Kyu, Cho, Pyo Yun, Ahn, Seong Kyu, Kim, Tong-Soo
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Antibodies, Protozoan - blood; Antibodies, Protozoan - immunology; Antibody Formation; Antigens, Protozoan - immunology; Base Sequence; Humans; India; Malaria, Vivax - diagnosis; Malaria, Vivax - epidemiology; Malaria, Vivax - immunology; Merozoite Surface Protein 1 - genetics; Merozoite Surface Protein 1 - immunology; Original; Plasmodium vivax - genetics; Plasmodium vivax - immunology; Protozoan Proteins - genetics; Protozoan Proteins - immunology; Reagent Kits, Diagnostic; Recombinant Proteins - immunology; Republic of Korea - epidemiology; Sequence Analysis, DNA; Seroepidemiologic Studies; Uganda; 예방의학
• ISSN: 0023-4001; 1738-0006; 2982-5164; 1738-0006; 2982-6799
• DOI: 10.3347/kjp.2014.52.2.143

To evaluate the seroprevalence against circumsporozoite protein (CSP) of Plasmodium vivax in sera of Korean patients, the central repeating domain (CRD) of CSP was cloned and analyzed. From the genomic DNA of patient's blood, 2 kinds of CSPs were identified to belong to a VK210 type, which is the dominant repeating of GDRA(D/A)GQPA, and named as PvCSPA and PvCSPB. Recombinantly expressed his-tagged PvCSPA or PvCSPB in Escherichia coli reacted well against sera of patients in western blot, with the detecting rate of 47.9% (58/121), which included 15 cases positive for PvCSPA, 6 cases positive for PvCSPB, and 37 cases for both. The mixture of PvCSPA and PvCSPB was loaded to a rapid diagnostic test kit (RDT) and applied with the same set of patient sera, which resulted in detection rates of 57.0% (69/121). When the protein sequences of PvCSPA were compared with those of P. vivax in endemic regions of India and Uganda, they were compatibly homologous to PvCSPA with minor mutations. These results suggested that the recombinant PvCSPA and PvCSPB loaded RDT may be a milestone in latent diagnosis which has been a hot issue of domestic malaria and important for radical therapy in overlapped infections with P. falciparum in tropical and subtropical areas. During the biological process of malarial infection, exposure of CSP to antigen-antibody reaction up to 57.0% is the first report in Korea.